<DOC>
	<DOCNO>NCT01600859</DOCNO>
	<brief_summary>Subjects adult age 50 85 year subjective memory complaint mild cognitive impairment mild dementia due Alzheimer 's disease ( AD ) . Subjects take thyroxine thyroid supplement subject receive acetylcholinesterase inhibitor ( AChEI ) and/or memantine AD must stable dose least 12 week prior Screening remain stable dose throughout trial . Subjects receive placebo single oral dose E2609 . Safety assessment conduct . Additionally , pharmacokinetics E2609 drug effect evaluate use cerebrospinal fluid biomarkers cognitive psychological measure .</brief_summary>
	<brief_title>Evaluation E2609 Subjects With Mild Cognitive Impairment Mild Dementia Due Alzheimer 's Disease ( Study : E2609-A001-101 Amendment 02 )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Inclusion criterion : Meets current cognitive classification MCI mild dementia due AD pathology ( subject `` positive '' biomarker amyloid Î² ) define National Institute Aging Alzheimer 's Association ( NIAAA ) research criterion Aged 50 85 year , inclusive time consent Exclusion criterion : Currently neurological condition AD ( Alzheimer 's disease ) relate could contribute subject 's cognitive impairment Significant pathological finding brain MRI Screening , include limited multiple microhemorrhages Any psychiatric diagnosis symptom , e.g. , hallucination , major depression , anxiety delusion Investigator 's opinion could interfere assessment cognition confound diagnosis MCI mild dementia due AD subject . A lifetime history cerebrovascular event nonvasovagal related loss consciousness within last 10 year Any abnormality ECG Screening and/or Baseline ( include QRS &gt; 110 m , abnormal electrical axis , PR interval &gt; 220 ms conduction abnormality ) consider clinically significant investigator History cardiac arrhythmia , ischemic heart disease cerebrovascular disease Lower spinal malformation physical lumbar spine radiography , local spinal infection , abnormality , include limited obesity , would prevent LP insertion indwell catheter CSF sample Any history seizure disorder , symptomatic seizure ( include history simple febrile seizure childhood ) past present medical condition , opinion investigator potential reduce seizure threshold ( e.g. , history head trauma concussion , previous alcohol abuse , substance abuse ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>